New pill that slows incurable breast cancer approved for NHS

A new type of drug for one of the most common kinds of advanced breast cancer is now available on the NHS in England.
Some 3,000 women a year could benefit from capivasertib after a clinical trial showed it can slow progression of the disease, and shrink tumours in a quarter of people.
The drug has been given the green light for NHS funding by England’s drug assessment body.
It’s one of a range of treatment options available to people whose cancer has spread and is no longer curable, but a cancer charity said breast cancer drugs should be approved more quickly.
Breast cancer is the most common cancer in the UK, with one in seven women affected in their lifetimes and 75% surviving for 10 years or more after diagnosis.

Source: BBC | Language: English